GL1X · GenesisL1 explorer

MolNFT v1 · #117255 · protein

Crystal structure of human carbonic anhydrase isozyme I with 3- (cyclooctylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl) SULFONYL]BENZENESULFONAMIDE

5E2M · Carbonic anhydrase 1: “Crystal structure of human carbonic anhydrase isozyme I with 3…”. X-ray diffraction, 2 ligands (V14, ZN), 4 pockets (best druggability 0.57). MolNFT v1 #117255 on GenesisL1: 3D structure, binding sites and…

PDB
5E2M
Type
protein
Length
513 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Carbonic anhydrase 1
EC
4.2.1.1
UniProt
P00915
Ligands
V14, ZN
Pockets
4 · best druggability 0.57

Structure

x-ray diffraction · 2 distinct chains · 16% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACarbonic anhydrase 1 (EC 4.2.1.1)protein25617% helix, 30% strandP00915
BCarbonic anhydrase 1 (EC 4.2.1.1)protein25715% helix, 30% strandP00915

Ligands and binding sites

  • V14 · 3-(cyclooctylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • PEG · Di(hydroxyethyl)ether · additive · 2 copies · chains B
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11980.570.8028V14
21650.530.7924V14
3610.360.7814empty
4590.330.7716empty

Compared structures

  • 5E2M · Crystal structure of human carbonic anhydrase isozyme I with… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00915 · AlphaFold monomer V2.0 prediction for carbonic anhydrase 1 (P00915) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.